470 related articles for article (PubMed ID: 19616319)
1. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
Monteleone G; Pallone F; Macdonald TT
Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease.
Monteleone G; Pallone F; Macdonald TT
Cytokine Growth Factor Rev; 2009 Apr; 20(2):185-91. PubMed ID: 19261537
[TBL] [Abstract][Full Text] [Related]
3. Role of IL-21 in inflammatory bowel disease.
Pallone F; Fina D; Caruso R; Monteleone G
Expert Rev Clin Immunol; 2010 Jul; 6(4):537-41. PubMed ID: 20594126
[TBL] [Abstract][Full Text] [Related]
4. Targeting interleukin-21 in inflammatory diseases.
Sarra M; Franzè E; Pallone F; Monteleone G
Expert Opin Ther Targets; 2011 Jun; 15(6):695-702. PubMed ID: 21391901
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 as a therapeutic target in candidate inflammatory diseases.
Nishimoto N
Clin Pharmacol Ther; 2010 Apr; 87(4):483-7. PubMed ID: 20182422
[TBL] [Abstract][Full Text] [Related]
6. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
7. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Williams RO; Paleolog E; Feldmann M
Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
[TBL] [Abstract][Full Text] [Related]
8. Targeting interleukin-21 in immune-mediated pathologies.
Sarra M; Pallone F; Macdonald TT; Monteleone G
Curr Drug Targets; 2010 May; 11(5):645-9. PubMed ID: 20014999
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 21 as a target of intervention in autoimmune disease.
Ettinger R; Kuchen S; Lipsky PE
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii83-6. PubMed ID: 19022821
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-21 in chronic inflammatory diseases.
Sarra M; Pallone F; Monteleone G
Biofactors; 2013; 39(4):368-73. PubMed ID: 23553807
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-21 in T cell-mediated diseases.
Monteleone G; Sarra M; Pallone F
Discov Med; 2009 Oct; 8(42):113-7. PubMed ID: 19833056
[TBL] [Abstract][Full Text] [Related]
12. Biological agents targeting interleukin-18.
Jelusic M; Lukic IK; Batinic D
Drug News Perspect; 2007 Oct; 20(8):485-94. PubMed ID: 18080035
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 therapy--review of a new approach.
Asadullah K; Sterry W; Volk HD
Pharmacol Rev; 2003 Jun; 55(2):241-69. PubMed ID: 12773629
[TBL] [Abstract][Full Text] [Related]
14. IL-21 as a therapeutic target in inflammatory disorders.
Di Fusco D; Izzo R; Figliuzzi MM; Pallone F; Monteleone G
Expert Opin Ther Targets; 2014 Nov; 18(11):1329-38. PubMed ID: 25162763
[TBL] [Abstract][Full Text] [Related]
15. IL-33: a potential therapeutic target in autoimmune diseases.
Wang S; Ding L; Liu SS; Wang C; Leng RX; Chen GM; Fan YG; Pan HF; Ye DQ
J Investig Med; 2012 Dec; 60(8):1151-6. PubMed ID: 23076162
[TBL] [Abstract][Full Text] [Related]
16. Interleukins in immunologic and allergic diseases.
Herrod HG
Ann Allergy; 1989 Oct; 63(4):269-72. PubMed ID: 2679243
[TBL] [Abstract][Full Text] [Related]
17. Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces.
Sonnenberg GF; Fouser LA; Artis D
Adv Immunol; 2010; 107():1-29. PubMed ID: 21034969
[TBL] [Abstract][Full Text] [Related]
18. Targeting IL-23 in autoimmunity.
Hölscher C
Curr Opin Investig Drugs; 2005 May; 6(5):489-95. PubMed ID: 15912962
[TBL] [Abstract][Full Text] [Related]
19. Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32).
Conti P; Youinou P; Theoharides TC
Autoimmun Rev; 2007 Jan; 6(3):131-7. PubMed ID: 17289547
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.
Taylor PC; Williams RO; Feldmann M
Curr Opin Biotechnol; 2004 Dec; 15(6):557-63. PubMed ID: 15560982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
